BANK VONTOBEL/CALL/BRISTOL-MYERS SQUIBB/54/0.1/20.09.24 Stock BANK VONTOBEL/CALL/BRISTOL-MYERS SQUIBB/54/0.1/20.09.24
Add to a list
To use this feature you must be a member
Log inSign up

BANK VONTOBEL/CALL/BRISTOL-MYERS SQUIBB/54/0.1/20.09.24 Share Price

Warrant

DE000VM7NZ11

Market Closed - Deutsche Boerse AG 18:45:08 28/06/2024 BST
0.009 EUR 0.00% Intraday chart for BANK VONTOBEL/CALL/BRISTOL-MYERS SQUIBB/54/0.1/20.09.24
Current month-25.00%
1 month-10.00%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Chart BRISTOL-MYERS SQUIBB COMPANY
Chart BANK VONTOBEL/CALL/BRISTOL-MYERS SQUIBB/54/0.1/20.09.24

Latest news about BRISTOL-MYERS SQUIBB COMPANY

Purple Biotech Says Interim Data from Pancreatic Cancer Drug Study Shows Promise MT
2seventy bio Sells Hemophilia A Candidate, Gene Editing Technology to Novo Nordisk; Shares Rise After Hours MT
Top Midday Stories: Southwest Cuts Q2 Guidance; HHS to Lower Costs for Medicare Enrollees on 64 Drugs; Bosch Weighing Acquisition Offer for Whirlpool; Novo Nordisk to Record $816.2 Million Impairment MT
Biden Administration to Lower Costs for 64 Prescription Drugs for Medicare Enrollees MT
More news

Quotes 5-day view

Date Price Change
28/06/24 0.009 0.00%
27/06/24 0.009 -10.00%
26/06/24 0.01 +25.00%
25/06/24 0.008 0.00%
24/06/24 0.008 -20.00%

Delayed Quote Deutsche Boerse AG

Last update June 28, 2024 at 06:45 pm

More quotes

Static data

Product typePlain-Vanilla-Warrants
Buy / SellCALL
Underlying BRISTOL-MYERS SQUIBB COMPANY
IssuerLogo Issuer Vontobel Vontobel
WKN VM7NZ1
ISINDE000VM7NZ11
Date issued 29/12/2023
Strike 54 $
Maturity 20/09/2024 (82 Days)
Parity 10 : 1
Emission price 0.29 €
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 0.42 €
Lowest since issue 0.007 €
Spread 0.012 €
Spread %60.00%

Company Profile

Bristol-Myers Squibb Company est spécialisé dans le développement, la fabrication et la commercialisation de produits pharmaceutiques. Les produits sont destinés au traitement des cancers, des maladies cardio-vasculaires, de l'hépatite, des maladies immunitaires et des désordres psychiatriques. The United States account for 70.1% of net sales.
Sector
-
More about the company

Ratings for Bristol-Myers Squibb Company

Trading Rating
Investor Rating
ESG Refinitiv
B
More Ratings

Consensus: Bristol-Myers Squibb Company

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
26
Last Close Price
41.53 USD
Average target price
53.19 USD
Spread / Average Target
+28.09%
Consensus
  1. Stock Market
  2. Warrants
  3. Warrant